New stock news | Tianxing Medical's secondary listing on the Hong Kong Stock Exchange

According to the disclosure by the Hong Kong Stock Exchange on March 3rd, Beijing Tianxing Medical Co., Ltd (referred to as Tianxing Medical) submitted an application for listing on the main board of the Hong Kong Stock Exchange, with CITIC SEC and CICC International as its joint sponsors. This is the company's second submission to the Hong Kong Stock Exchange. According to data from Zuo Shi Zi Xun, based on sales revenue in 2024, the company is the fourth largest sports medicine equipment provider in China, with a market share of approximately 6.5% in the Chinese sports medicine implants and instruments market, and is also the largest domestic sports medicine equipment provider. According to the prospectus, the company is a China-based medical device company, focusing on clinical solutions for sports medicine. With its independently developed implants, active devices, related consumables, and surgical instruments, the company provides comprehensive solutions for the treatment of soft tissue injuries in the shoulders, knees, hips, ankles/feet, elbows, and hands/wrists, as well as sports rehabilitation and prevention.